Browse Companies

Orion Group Holdings Inc, operating in marine and concrete construction segments, has demonstrated a recovery in profitability and operating cash flow in 2025 after multi-year losses. The company benefits from specialized capabilities and strategic presence in Texas and government contracts but faces revenue volatility due to project-based work and regulatory complexities. Its substantial $22 billion pipeline signals growth potential, yet heavy capital spending and moderate liquidity underline financial pressures that warrant ongoing monitoring. Backlog contraction after peak projects and dependency on project timing remain key operational risks.

Sight Sciences, Inc. develops proprietary devices targeting interventional glaucoma and dry eye markets with flagship products including OMNI, SION, and TearCare. Since inception, the company has operated at a loss, driven by heavy investments in clinical trials, sales expansion, and regulatory initiatives. Revenue growth hinges on broader physician adoption and expanded reimbursement coverage, especially for TearCare. While operating losses narrowed in 2025 compared to prior years, cash flow remains negative, reflecting ongoing investment needs. Operational risks stem from concentrated third-party manufacturing and competitive market dynamics.

Aquestive Therapeutics, Inc. operates with distinct oral film delivery technology and an innovative epinephrine prodrug platform but struggles with expanding operating losses and regulatory setbacks. The company’s revenue base is anchored by licensed products it manufactures exclusively, while its pipeline projects like Anaphylm™ face significant FDA challenges. Liquidity constraints are pressing, with increasing debt servicing requirements starting mid-2026 that could hinder growth prospects unless refinanced. Investors should monitor FDA review outcomes for pipeline assets and the company’s ability to secure capital amidst commercial launch costs.

In fiscal 2025, CompX International Inc. reported operating income growth of nearly 33% to $22.6 million, driven by improved margins and operational leverage across its Security Products and Marine Components segments. While net sales declined slightly year-over-year to $158.3 million, reflecting mixed demand conditions, the company sustained strong operating cash flow near $22.9 million and increased capital expenditures to $3.7 million to support capacity and maintenance. Capital allocation favored shareholder returns with consistent dividends supplemented by special payouts, while share repurchases remained authorized but inactive. Legal risks from PFAS-related litigation persist, though no losses have been accrued and the company continues vigorous defense efforts. CompX's manufacturing facilities remain ISO-9001 certified with a predominantly domestic supply chain mitigating some raw material cost pressures amid tariff challenges.

In its latest quarterly filing for Q1 2026, NN INC demonstrated revenue growth against comparable prior-year periods, reflecting new business wins and favorable sales mix despite persistent macroeconomic pressures. The company continues to optimize its global manufacturing footprint through plant closures and operational efficiency initiatives. NN INC’s diverse industrial portfolio, anchored by Mobile and Power Solutions segments, leverages advanced engineering and materials science expertise in high-precision components for automotive, electrical, and medical end markets globally. Key risks include raw material price volatility and geopolitical trade uncertainties. The path ahead centers on expanding targeted growth markets and managing cost structures amid evolving demand dynamics.

Mayville Engineering Company, Inc. (MEC) maintains its position as the largest U.S. fabricator with broad capabilities and a diversified customer base spanning heavy vehicles to data centers. Historically profitable with double-digit operating income growth from 2022 to 2024, MEC took a notable operating loss in 2025 despite strong cash flow generation. The company’s growth is anchored by embedded OEM relationships, technological investments, and its ability to pass commodity cost fluctuations to customers, but risks include macroeconomic volatility, operational execution, and acquisition integration. Key factors to monitor include return to profitability, capital deployment in high-growth segments like data center power solutions, and how MEC manages cost pressures within its vertical integration model.

Nine Energy Service, Inc. has emerged from Chapter 11 bankruptcy in March 2026, applying fresh start accounting that resets its financial reporting and operational baseline. The May 2026 quarterly filing details ongoing restructuring impacts on supplier and customer relationships, underscoring risks in contract renewals and financing while highlighting a specialized business model focusing on completion tools for the US onshore oil and natural gas sector. Competitive pressures remain acute in a fragmented industry, but growth can be supported by shale drilling activity and technological advancements in hydraulic fracturing completions. Investors should track contract backlog development and refinancing progress as key near-term indicators.

PepGen Inc. remains focused on advancing its lead candidate PGN-EDODM1 for myotonic dystrophy type 1 amidst a partial FDA clinical hold affecting its FREEDOM2 trial's multiple ascending dose segment. The company’s highly specialized EDO platform underpins a differentiated therapeutic approach but is contingent on clinical progress and regulatory clearance. Liquidity remains sufficient for near-term activities though capital needs depend heavily on navigating FDA requirements, trial outcomes, and manufacturing scale-up. Long-run prospects hinge on successful trial resolution and market acceptance within the rare genetic disorder space.

Global Water Resources, Inc. operates water, wastewater, and recycled water utilities primarily in Arizona leveraging a Total Water Management approach to address regional water scarcity sustainably. While historical revenue growth has been steady, recent earnings and margins have declined amid large infrastructure investments and regulatory risks tied to utility rate cases overseen by the Arizona Corporation Commission. The company’s future growth depends on strategic expansions within regulated service areas, managing capital intensity, and navigating evolving water supply constraints. Capital allocation priorities currently emphasize infrastructure spending and dividends with limited free cash flow generation.

Third Coast Bancshares reported substantial loan growth to $5.2 billion as of March 31, 2026, up from $4.35 billion at year-end 2025, supported by strong commercial and industrial lending. Deposits increased to $5.72 billion, reflecting a stable and growing core funding base amid expanding branch presence in key Texas markets. The company extended its senior line of credit facility and maintains a robust liquidity profile, with $425 million in cash and equivalents, while executing disciplined risk management grounded in an NIST-aligned cybersecurity program. These developments underpin Third Coast’s regional banking strategy focused on small- and medium-sized businesses in Texas, leveraging local market expertise and relationship-driven lending to sustain competitive advantages and growth opportunities.

SCYNEXIS, Inc. continues to develop novel antifungal agents rooted in its proprietary fungerps platform, achieving FDA approval for ibrexafungerp and advancing second-generation candidate SCY-247 through Phase 1 trials. In 2025, the company reported a narrower net loss driven by licensing revenues from its deal with GlaxoSmithKline (GSK), balancing heavy R&D costs. SCYNEXIS's expanding pipeline and strategic licensing underpin its efforts to address serious fungal infections, though regulatory complexities and financial sustainability remain key challenges to monitor.

ASPAC III Acquisition Corp., a British Virgin Islands-incorporated SPAC, raised approximately $60 million in its November 2024 IPO, funds held in trust pending business combination. The company has no operating revenues and incurs administrative costs typical of pre-combination SPACs. In May 2025, ASPAC III entered a stock-for-stock merger agreement with Bioserica International Limited, valued at roughly $218 million, marking a strategic pivot into the ESG-aligned bio-based antimicrobial materials sector. The SPAC's financials reflect widening operating losses but a positive net income largely driven by non-operating accounting adjustments. Key risks remain around closing the transaction by the November 2026 deadline. Post-merger success depends on operational integration and growth execution.

Atlas Lithium Corporation is focused on developing its hard-rock lithium project in Minas Gerais, Brazil, holding extensive mineral rights in a recognized lithium pegmatitic district. Despite commissioning a dense media separation plant designed to produce substantial lithium concentrate, the company continues to report significant net losses and negative cash flows typical of exploration-stage miners. Regulatory hurdles, community opposition, and dependence on capital markets compound operational risks. Key upcoming milestones include ramping plant operations and securing permits, which will determine prospects for transitioning toward positive cash flow and commercial production.

Rigetti Computing has pioneered a patented modular quantum processor architecture that promises scalability in quantum computing, supported by its vertically integrated Fab-1 wafer fabrication facility. Despite generating revenue since 2018 across multiple streams including QCaaS and quantum processors, the company faced a 34% revenue decline in 2025 to $7.1 million alongside mounting operating losses totaling $84.7 million. Its heavy investments in R&D aim to overcome technological bottlenecks, but the nascent market and competitive landscape pose significant risks. Strong balance sheet liquidity contrasts with cash burn exceeding $77 million, with no dividends or buybacks planned, reflecting a capital-intensive pursuit of quantum advantage and commercial viability.

TriplePoint Venture Growth BDC Corp. delivered a 54% rise in net income for FY2025 to $49.2 million, recovering from prior losses, as the company adjusted to falling interest rates impacting yields. The business development company grew its investment portfolio to represent over 93% of assets while actively managing credit facilities and senior notes, including repaying the maturing $200 million 2026 Notes with proceeds from a recent $75 million private note offering. Despite softer operating cash flow, TPVG maintained a disciplined approach to dividends and capital allocation while expanding unfunded commitments substantially year-over-year.

OmniAb, Inc. has expanded its partner base to over 100 entities and grown its active discovery programs to more than 400 by the end of 2025, reflecting solid adoption of its multi-species transgenic antibody platform. This biological and AI-powered technology uniquely positions OmniAb in the competitive therapeutic discovery sector. However, financial results remain challenged with a $69 million operating loss in 2025, driven by ongoing development investments. Additionally, evolving U.S. and global healthcare pricing reforms pose risks to the realization of milestone and royalty revenues tied to partners’ commercial success.

Riley Exploration Permian, Inc. (REPX) operates predominantly in oil-rich horizontal drilling in the Permian Basin with a strategic emphasis on returns and free cash flow generation. While revenue slightly declined in 2025 due to lower commodity prices, net income rose robustly, supported by asset sales and derivative hedges. The company undertook a sizable acreage acquisition and completed a midstream sale that strengthened liquidity amid capital-intensive operations. Despite a working capital deficit and reliance on credit facilities, REPX maintains a resilient balance sheet with manageable leverage and ongoing shareholder returns through dividends. Future growth hinges on production optimization, commodity price trajectories, and further strategic acquisitions within its core Texas-New Mexico footprint.

In Q1 2026, Viemed Healthcare expanded its equipment and supply sales dramatically, primarily fueled by the Lehan acquisition and scaling PAP resupply programs, while healthcare staffing services saw a modest decline. The company's integrated home respiratory care model continues to drive patient outcomes across all 50 states, supported by a sizable licensed respiratory therapist workforce. Strategic growth hinges on further geographic expansion, women’s health product line growth, and clinical staffing increases, but regulatory oversight and reimbursement uncertainties remain material risks. Liquidity remains adequate with $9.8 million cash and manageable debt of $9.2 million as of March 31, 2026.

Middleby Corp experienced robust revenue growth of 19.6% in FY2025, driven primarily by its Commercial Foodservice segment and resilient long-term contract execution in Food Processing. However, this came with a dramatic net income decline of 91.4%, heavily impacted by significant impairment charges related to its discontinued Residential Kitchen Equipment operations. The company is proceeding with a spin-off of its Food Processing segment, aiming to concentrate resources and strategic focus on Commercial Foodservice Equipment. Capital structure adjustments ahead of the spin-off include amended credit facilities and substantial debt repayments, while capital allocation has notably skewed toward aggressive share repurchases despite subdued ROE near 1.3%. Key metrics to monitor post-spin include segment-specific revenue contribution, margin sustainability amid inflationary pressures, and contract backlog developments.

BioLargo, Inc. operates through multiple subsidiaries with a portfolio of 34 patents focused on odor control, energy storage batteries, and medical wound care products. Revenue expanded from $281K in 2016 to $12.2M in 2023, yet operating losses widened sharply to $14.9M by 2025 amid sustained R&D investment and scale-up efforts. The company’s liquidity remains tight with current assets of $5.1M nearly matching current liabilities of $5.1M at year-end 2025. Capital has been raised primarily via equity sales under a Lincoln Park purchase agreement, generating over $3 million gross proceeds in 2025. Growth depends on commercializing technologies like the Cellinity™ liquid sodium battery and CupriDyne® Clean odor solutions while managing risks from key customer defaults and operational scaling hurdles [F1][S3][S15][S9].

Red Violet, Inc. has demonstrated robust financial growth through its AI- and machine learning-enabled identity intelligence solutions, primarily delivered under the IDI and FOREWARN brands. FY2025 saw a 20% increase in revenue and a near doubling of operating profit supported by scalable SaaS economics and expanding billable customers. Its CORE platform integrates large proprietary and public data assets with embedded AI workflows, establishing a durable competitive moat. However, supplier concentration risks related to data acquisition remain a notable factor, mitigated in part by long-term agreements. Strong operating cash flow generation has enabled conservative capital returns and investment. Monitoring customer expansion rates, contract renewals, and new product uptake is critical for assessing future growth.

Safeguard Acquisition Corp. (SAC) is a Cayman Islands-incorporated special purpose acquisition company (SPAC) formed in late 2025, with the core objective of completing a Business Combination to transition into an operating entity. The latest quarterly filing confirms no material change in risk profile nor progress toward target identification, reflecting the early stage of SAC’s lifecycle. SAC’s competitive positioning depends largely on management’s ability to finalize a suitable deal within restrictive timeframes, while maintaining shareholder value amid dilution risks. Its business model revolves around deploying approximately $220 million held in trust to acquire controlling interests in target companies, often abroad, necessitating careful navigation of cross-border regulatory and operational complexities.

Roman DBDR Acquisition Corp. II’s Q1 2026 10-Q filing highlights key operational and governance developments including sponsor and shareholder redemption waivers, stable trust account investments, and board refreshment with new independent director and CTO appointments. Structured as a Cayman Islands SPAC focused on sustainable energy technology, it faces typical SPAC-related execution risks, regulatory scrutiny, and liquidity constraints ahead of completing its merger with ThomasLloyd Climate Solutions. Despite a low current ratio reflecting pre-combination capital deployment, strategic leadership enhancements signal preparedness for post-merger integration.

Latham Group transitioned from a net loss in 2024 to profitability in 2025, underpinned by increased fiberglass pool penetration and integrated acquisitions boosting sales. Operating income rose sharply by over 67% year-over-year, while Adjusted EBITDA margins improved to 18.3%. The company plans to leverage direct-to-homeowner digital marketing and dealer capacity expansions to sustain growth despite a largely flat market environment. Capital discipline is evident in improved cash flows and deleveraging efforts with no outstanding revolver borrowings at year-end.

MicroVision, Inc.'s Q1 2026 filings highlight ongoing heavy investment in expanding its lidar sensor technology portfolio, including the recent acquisition of Luminar Technologies’ assets. The company remains focused on commercializing advanced lidar solutions for automotive ADAS and industrial markets, relying heavily on partnerships with OEMs and Tier 1 suppliers. Despite strategic acquisitions bolstering its technology base, MicroVision continues to operate at a loss, faces significant capital requirements, and navigates competitive pressures from larger players. Near-term growth hinges on successful product commercialization and securing additional capital under constrained liquidity conditions.

Seaport Entertainment Group's Q1 2026 10-Q highlights a strong liquidity position with $115 million in cash against approximately $38 million in debt, preserving flexibility for strategic growth. The company's diversified portfolio across hospitality, entertainment venues, and prime real estate in New York City's Seaport district and Las Vegas underpins a multi-touchpoint destination model focused on experiential offerings. Growth is further fueled by key partnerships, notably with Jean-Georges Restaurants, and potential monetization of its Fashion Show Mall Air Rights asset. Despite inherent risks including ongoing operating losses and seasonal demand fluctuations, SEG’s distinctive asset base and strategic ventures position it to capitalize on evolving consumer preferences and urban entertainment trends.

Everspin Technologies advanced its MRAM business in 2025 with a notable increase in product sales fueled by record design wins, pushing annual revenue to $55.2 million, a 9.5% rise year-over-year. Despite this top-line growth, gross margins compressed slightly due to a changing revenue mix and operational expenses edged higher. The company sustained positive operating cash flow and escalated capital expenditures, underscoring its commitment to manufacturing scale-up and R&D pipelines. Key risks include ongoing patent litigation and significant customer concentration, particularly in Asia-Pacific where most revenues accrue.

Caesarstone Ltd. has experienced significant revenue contraction and margin pressure through 2025, driven by macroeconomic headwinds, seasonal fluctuations, and ongoing silicosis litigation. Despite continuing to pursue growth via acquisitions and manufacturing optimization, the company faces negative operating cash flows and high legal provisions that strain liquidity. U.S. market opportunities remain pivotal but are tempered by cost inflation and regulatory uncertainties. Investors should monitor margins, litigation developments, and geographic revenue shifts for signals of operational stabilization.

In its Q1 2026 filing, Ring Energy reported continued financial strain characterized by a low current ratio and net losses, yet management has executed actions targeting cash flow enhancements and debt reduction. The company’s core business remains anchored in oil and gas production, but it faces significant industry headwinds including commodity price volatility and narrow financial flexibility. Equity-based performance incentives signal a push for operational discipline. Key risks include liquidity constraints and cybersecurity exposures, while growth hinges on efficient asset utilization and capital structure management.

Village Super Market’s Q3 fiscal 2026 results reveal typical margin pressure in a highly competitive grocery market, with gross profit margin declining from 28.77% to 28.08% and operating margin retreating to about 1.5%. Despite this, operating income remained positive, supported by tight control of operating expenses and steady interest costs. The company leverages its Wakefern cooperative membership for purchasing scale and operates multiple store banners targeting diverse customer segments. Growth drivers include loyalty program expansion and digital ordering, but risks persist from intense competition, narrow margins, and ongoing legal disputes with Wakefern. Liquidity is solid with $128.7 million cash on hand and robust operating cash flow, ensuring capacity for capital investments and debt servicing.

In 2025, NACCO Industries Inc experienced a pronounced 63.1% drop in revenue year-over-year, driven by shifts across its Utility Coal Mining, Contract Mining, and Minerals and Royalties segments. Despite top-line challenges, the company recorded a strong rebound in operating cash flow (+128.4% YoY), reflecting operational efficiencies and cost management amidst volatile commodity dynamics. Capital allocation remained disciplined with lower capital expenditures and ongoing dividends and buybacks, all supported by a solid liquidity position entering 2026. Key risks include commodity price volatility and regulatory compliance costs affecting long-term growth sustainability.

Silver North Resources Ltd. specializes in silver exploration with primary projects in the Yukon Territory, Canada. Over recent years, the company has shown fluctuating financial performance marked by losses driven by exploration expenditures, with no proven mineral reserves yet reported. Its operations rely substantially on equity financings and partnerships, such as its option agreement with Coeur Mining. The company faces inherent risks typical of early-stage exploration including market volatility, regulatory complexities, and the speculative nature of its resource base. Looking forward, Silver North’s growth and operational sustainability hinge on successful capital raises and exploration results that can unlock economic deposits.

Octave Specialty Group, Inc. operates through two distinct but complementary segments: Insurance Distribution and Specialty Property and Casualty Insurance. The company has pursued growth via acquisitions, strategic investments, and launching new MGAs while navigating the regulatory frameworks across multiple jurisdictions. Its financial performance in recent years has been mixed: revenues showed modest growth in 2025 following sharp declines from 2022 to 2024, while net losses markedly improved but remain substantial. Leveraging an extensive investment portfolio aligned with liability profiles, OSG faces capital allocation challenges exacerbated by significant indebtedness incurred in late 2025. Risk factors including market cyclicality, regulatory constraints, FX exposure, and talent competition add complexity to its strategic trajectory.

European Wax Center, Inc. (EWCZ) completed its acquisition by Glow Midco, LLC in early May 2026, transitioning from a publicly traded company to a private entity. The latest quarterly filing reports ongoing operational profitability and underscores the company’s reliance on its franchising business model. This ownership change enhances strategic flexibility but introduces new governance and execution dynamics that may impact franchisee performance and the brand’s market position. Key growth drivers remain network expansion and brand loyalty, though risks related to franchisee compliance, labor availability, and supply chains persist.

Miller Industries experienced a pronounced contraction in 2025, with net sales falling by over 37% and net income tumbling nearly 64%, reflecting significant supply chain disruptions, regulatory pressures, and reduced demand. Despite these setbacks, the company’s dominant position as the largest global manufacturer of towing equipment, its highly exclusive distributor network, and ongoing investments in advanced manufacturing underscore resilience. A striking surge in operating cash flow contrasts with the earnings drop, highlighting working capital shifts amid inventory correction. The company's disciplined capital allocation through dividends and share repurchases, alongside a strong liquidity profile supported by a $100 million credit facility, positions it to manage near-term volatility. Risks around key executive dependencies and evolving regulations persist as critical factors to monitor.

Cardlytics operates a commerce media platform that uses anonymized purchase data from financial institution partners to drive targeted advertising through consumer incentives. Over the past several years, Cardlytics has experienced declining revenues, hitting $233 million in 2025, down 16% year over year from 2024, while continuing to report substantial net losses. The company’s growth prospects hinge on expanding partnerships and diversifying marketers but are constrained by macroeconomic uncertainties and dependence on a few large financial institution partners. Liquidity remains adequate following debt refinancing and capital raises, but operating cash flow improvements have yet to translate into profitability.